- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Amgen scores with trial of on-body injected version of Tepezza in thyroid eye disease | ||
| Mo | VML Health urges marketers to shift from lifespan to 'joyspan' as patient goals evolve | ||
| Mo | Eli Lilly takes the court with 150th anniversary campaign to catch Final Four crowd | ||
| 03.04. | An update on the pharma industry's reshoring effort | ||
| 02.04. | Trump slaps 100% duties on imported drugs but leaves plenty of exceptions | ||
| 02.04. | UK signs off on US pharma deal, ensuring tariff reprieve as Britain aims to reattract investments | ||
| 02.04. | BioNTech telegraphs closure of Singapore vaccine facility amid efforts to 'align capacity' | ||
| 02.04. | Rising Stars: The Trade Desk's Elizabeth Keenan finds the rhythm in music and media | ||
| 02.04. | Trump eyes 100% tariff rate for companies that have not struck MFN deals: Bloomberg | ||
| 02.04. | Poland, Romania must pay Pfizer $2.2B in fight over contested COVID vaccine doses: Belgian court | ||
| 02.04. | Lilly's obesity pill Foundayo gains early blockbuster forecast as analysts float 5M+ prescriptions in 2026 | ||
| 02.04. | Another AstraZeneca Emerald glimmers as Imfinzi, Imjudo delay liver cancer progression | ||
| 02.04. | Glenmark goes direct with new US Ryaltris marketing plan as it drops partner model | ||
| 02.04. | German CDMO Adragos buys French sterile injectables plant from Sanofi | ||
| 02.04. | Bayer rejigs marketing claims after recommendation from US advertising body | ||
| 02.04. | Regulatory tracker: Vertex secures broader FDA labels for cystic fibrosis meds Alyftrek, Trikafta | ||
| 01.04. | Lilly answers Novo's GLP-1 pill with highly anticipated FDA nod for Foundayo | ||
| 01.04. | Novo's Wegovy nets cardio nod from UK cost gatekeeper, adding 1M+ eligible patients | ||
| 01.04. | Evotec hires exec with AI experience to lead rebooted commercial team | ||
| 31.03. | FDA flags serious liver injury cases, 8 deaths with 'reasonable' link to Amgen's Tavneos | ||
| 31.03. | Novo Nordisk cuts 400 roles at troubled Bloomington site | ||
| 31.03. | Iterum initiates wind-down after failure to offload antibiotic with sluggish sales | ||
| 31.03. | API supplier BASF raises prices up to 20% in response to rising energy, raw material costs | ||
| 31.03. | Biogen, eyeing swift commercial tailwind, ponies up $5.6B for Apellis and its 2 approved meds | ||
| 31.03. | Insulet hires Stryker vet, reinstating commercial chief role as C-suite overhaul continues |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.